Dentistry. Implications and management of xerostomia in the HIV patient.
Shetty
Kishore
K
Department of General Dentistry, LSUHSC School of Dentistry, New Orleans, Louisiana, USA.
D023241:Antiretroviral Therapy, Highly Active; D018678:Cholinergic Agents / Q000627:therapeutic use; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D010862:Pilocarpine / Q000627:therapeutic use; D011812:Quinuclidines / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D013876:Thiophenes / Q000627:therapeutic use; D014987:Xerostomia / Q000150:complications* / Q000188:drug therapy / Q000628:therapy*
D018678:Cholinergic Agents; D017320:HIV Protease Inhibitors; D011812:Quinuclidines; D018894:Reverse Transcriptase Inhibitors; D013876:Thiophenes; D010862:Pilocarpine; C059240:cevimeline